DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

NCT06384573 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease
Dementia
Alzheimer's Disease, Familial

Interventions

DRUG: lecanemab

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]